Skip to main content
Top
Published in: The journal of nutrition, health & aging 7/2023

27-06-2023 | Sarcopenia | Original Research

Long-Term Mortality Risk in Older Adults with Sarcopenia: An 11-Year Prospective Cohort Study Comparing AWGS 2014 and AWGS 2019 Guidelines for Enhanced Clinical Utility and Accurate Risk Prediction

Authors: C.-K. Liang, L.-N. Peng, M.-H. Lin, C.-H. Loh, Wei-Ju Lee, F.-Y. Hsiao, L.-K. Chen

Published in: The journal of nutrition, health & aging | Issue 7/2023

Login to get access

Abstract

Objectives

To discern the diagnostic accuracy between the updated diagnostic consensus of the Asian Working Group for Sarcopenia (AWGS) in 2019 (AWGS 2019) and the previous AWGS 2014 guidelines.

Design

A prospective population-based cohort study.

Setting and Participants

The study included 731 older community-dwelling adults aged ≥ 65 years who participated in face-to-face interviews and were followed up for 11-year mortality until 31 Mar 2022.

Measurements

We utilized a handgrip strength dynamometer to measure participants’ muscle strength, while their walking speed was determined by a timed 6-meter walk test at their usual pace. Additionally, muscle mass was measured using dual-energy X-ray absorptiometry scanning. Sarcopenia was defined as the presence of low muscle mass in combination with weakness and/or slowness both by AWGS 2014 and 2019 criteria.

Results

The present study followed 731 participants (mean age 73.4 ± 5.4 years, men predominant 52.8%) over a period of 11 years, yielding 5927 person-years and 159 deaths. Prevalence of sarcopenia defined by AWGS 2019 and 2014 criteria were 8.5% and 6.8%, respectively. Sarcopenia defined by AWGS 2019 (HR 1.62, 95% CI 1.04–2.54, p=0.034) but not AWGS 2014 was significantly associated with mortality in community-living older adults after adjusting for potential confounders such as age, sex, education, drinking, disease burden and serum level of testosterone. The study also found that the AWGS 2019 criteria had a better model fitness than AWGS 2014 criteria in predicting mortality.

Conclusion

AWGS 2019 criteria outperformed AWGS 2014 in identifying sarcopenia risk and predicting mortality. Screening for sarcopenia in older adults may improve health outcomes by identifying those at increased mortality risk.
Appendix
Available only for authorised users
Literature
2.
go back to reference Borges RC, Correa DI, Correa LJS, Colombo AS, Carvalho CRF. Prevalence and Factors Associated with Sarcopenia in Hospitalized Elderly Patients. Aging Med Healthc. 2022;13:49–50.CrossRef Borges RC, Correa DI, Correa LJS, Colombo AS, Carvalho CRF. Prevalence and Factors Associated with Sarcopenia in Hospitalized Elderly Patients. Aging Med Healthc. 2022;13:49–50.CrossRef
3.
go back to reference Liu LK, Lee WJ, Chen LY, Hwang AC, Lin MH, Peng LN, et al. Sarcopenia, and its association with cardiometabolic and functional characteristics in Taiwan: results from I-Lan Longitudinal Aging Study. Geriatr Gerontol Int. 2014;14 Suppl 1:36–45. Epub 2014/01/24. doi: https://doi.org/10.1111/ggi.12208. PubMed PMID: 24450559.CrossRefPubMed Liu LK, Lee WJ, Chen LY, Hwang AC, Lin MH, Peng LN, et al. Sarcopenia, and its association with cardiometabolic and functional characteristics in Taiwan: results from I-Lan Longitudinal Aging Study. Geriatr Gerontol Int. 2014;14 Suppl 1:36–45. Epub 2014/01/24. doi: https://​doi.​org/​10.​1111/​ggi.​12208. PubMed PMID: 24450559.CrossRefPubMed
4.
go back to reference Peng LN, Yu PC, Hsu CC, Tseng SH, Lee WJ, Lin MH, et al. Sarcojoint(R), the branched-chain amino acid-based supplement, plus resistance exercise improved muscle mass in adults aged 50 years and older: A double-blinded randomized controlled trial. Exp Gerontol. 2022;157:111644. Epub 2021/11/29. doi: https://doi.org/10.1016/j.exger.2021.111644. PubMed PMID: 34838980.CrossRefPubMed Peng LN, Yu PC, Hsu CC, Tseng SH, Lee WJ, Lin MH, et al. Sarcojoint(R), the branched-chain amino acid-based supplement, plus resistance exercise improved muscle mass in adults aged 50 years and older: A double-blinded randomized controlled trial. Exp Gerontol. 2022;157:111644. Epub 2021/11/29. doi: https://​doi.​org/​10.​1016/​j.​exger.​2021.​111644. PubMed PMID: 34838980.CrossRefPubMed
5.
go back to reference Petermann-Rocha F, Balntzi V, Gray SR, Lara J, Ho FK, Pell JP, et al. Global prevalence of sarcopenia and severe sarcopenia: a systematic review and meta-analysis. J Cachexia Sarcopenia Muscle. 2022;13:86–99. Epub 2021/11/25. doi: https://doi.org/10.1002/jcsm.12783. PubMed PMID: 34816624; PubMed Central PMCID: PMCPMC8818604.CrossRefPubMed Petermann-Rocha F, Balntzi V, Gray SR, Lara J, Ho FK, Pell JP, et al. Global prevalence of sarcopenia and severe sarcopenia: a systematic review and meta-analysis. J Cachexia Sarcopenia Muscle. 2022;13:86–99. Epub 2021/11/25. doi: https://​doi.​org/​10.​1002/​jcsm.​12783. PubMed PMID: 34816624; PubMed Central PMCID: PMCPMC8818604.CrossRefPubMed
9.
go back to reference Lee WJ, Peng LN, Lin MH, Loh CH, Hsiao FY, Chen LK. Intrinsic capacity differs from functional ability in predicting 10-year mortality and biological features in healthy aging: results from the I-Lan longitudinal aging study. Aging (Albany NY). 2023;15. Epub 2023/02/08. doi: https://doi.org/10.18632/aging.204508. PubMed PMID: 36750172. Lee WJ, Peng LN, Lin MH, Loh CH, Hsiao FY, Chen LK. Intrinsic capacity differs from functional ability in predicting 10-year mortality and biological features in healthy aging: results from the I-Lan longitudinal aging study. Aging (Albany NY). 2023;15. Epub 2023/02/08. doi: https://​doi.​org/​10.​18632/​aging.​204508. PubMed PMID: 36750172.
13.
go back to reference DeLong ER, DeLong DM, Clarke-Pearson DL. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics. 1988;44:837–45. Epub 1988/09/01. PubMed PMID: 3203132.CrossRefPubMed DeLong ER, DeLong DM, Clarke-Pearson DL. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics. 1988;44:837–45. Epub 1988/09/01. PubMed PMID: 3203132.CrossRefPubMed
14.
go back to reference Pencina MJ, D’Agostino RB, Sr., D’Agostino RB, Jr., Vasan RS. Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond. Stat Med. 2008;27:157–72; discussion 207–12. Epub 2007/06/15. doi: https://doi.org/10.1002/sim.2929. PubMed PMID: 17569110.CrossRefPubMed Pencina MJ, D’Agostino RB, Sr., D’Agostino RB, Jr., Vasan RS. Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond. Stat Med. 2008;27:157–72; discussion 207–12. Epub 2007/06/15. doi: https://​doi.​org/​10.​1002/​sim.​2929. PubMed PMID: 17569110.CrossRefPubMed
16.
go back to reference Chen Z, Li WY, Ho M, Chau PH. The Prevalence of Sarcopenia in Chinese Older Adults: Meta-Analysis and Meta-Regression. Nutrients. 2021;13. Epub 2021/05/01. doi: https://doi.org/10.3390/nu13051441. PubMed PMID: 33923252; PubMed Central PMCID: PMCPMC8146971. Chen Z, Li WY, Ho M, Chau PH. The Prevalence of Sarcopenia in Chinese Older Adults: Meta-Analysis and Meta-Regression. Nutrients. 2021;13. Epub 2021/05/01. doi: https://​doi.​org/​10.​3390/​nu13051441. PubMed PMID: 33923252; PubMed Central PMCID: PMCPMC8146971.
17.
go back to reference Yuki A, Ando F, Otsuka R, Shimokata H. Sarcopenia based on the Asian Working Group for Sarcopenia criteria and all-cause mortality risk in older Japanese adults. Geriatr Gerontol Int. 2017;17:1642–7. Epub 2017/03/07. doi: https://doi.org/10.1111/ggi.12946. PubMed PMID: 28261905.PubMed Yuki A, Ando F, Otsuka R, Shimokata H. Sarcopenia based on the Asian Working Group for Sarcopenia criteria and all-cause mortality risk in older Japanese adults. Geriatr Gerontol Int. 2017;17:1642–7. Epub 2017/03/07. doi: https://​doi.​org/​10.​1111/​ggi.​12946. PubMed PMID: 28261905.PubMed
20.
go back to reference Kitamura A, Seino S, Abe T, Nofuji Y, Yokoyama Y, Amano H, et al. Sarcopenia: prevalence, associated factors, and the risk of mortality and disability in Japanese older adults. J Cachexia Sarcopenia Muscle. 2021;12:30–8. Epub 2020/11/27. doi: https://doi.org/10.1002/jcsm.12651. PubMed PMID: 33241660; PubMed Central PMCID: PMCPMC7890144.CrossRefPubMed Kitamura A, Seino S, Abe T, Nofuji Y, Yokoyama Y, Amano H, et al. Sarcopenia: prevalence, associated factors, and the risk of mortality and disability in Japanese older adults. J Cachexia Sarcopenia Muscle. 2021;12:30–8. Epub 2020/11/27. doi: https://​doi.​org/​10.​1002/​jcsm.​12651. PubMed PMID: 33241660; PubMed Central PMCID: PMCPMC7890144.CrossRefPubMed
25.
go back to reference Ko CH, Chuang HY, Wu SJ, Yu SC, Chang YF, Chang CS, et al. Changes of sarcopenia case finding by different Asian Working Group for Sarcopenia in community indwelling middle-aged and old people. Front Med (Lausanne). 2022;9:1041186. Epub 2022/11/26. doi: https://doi.org/10.3389/fmed.2022.1041186. PubMed PMID: 36425107; PubMed Central PMCID: PMCPMC9680091.CrossRefPubMed Ko CH, Chuang HY, Wu SJ, Yu SC, Chang YF, Chang CS, et al. Changes of sarcopenia case finding by different Asian Working Group for Sarcopenia in community indwelling middle-aged and old people. Front Med (Lausanne). 2022;9:1041186. Epub 2022/11/26. doi: https://​doi.​org/​10.​3389/​fmed.​2022.​1041186. PubMed PMID: 36425107; PubMed Central PMCID: PMCPMC9680091.CrossRefPubMed
26.
27.
go back to reference Lee D, Kim M, Won CW. Common and different characteristics among combinations of physical frailty and sarcopenia in community-dwelling older adults: The Korean Frailty and Aging Cohort Study. Geriatr Gerontol Int. 2022;22:42–9. Epub 2021/11/25. doi: https://doi.org/10.1111/ggi.14314. PubMed PMID: 34816568.CrossRefPubMed Lee D, Kim M, Won CW. Common and different characteristics among combinations of physical frailty and sarcopenia in community-dwelling older adults: The Korean Frailty and Aging Cohort Study. Geriatr Gerontol Int. 2022;22:42–9. Epub 2021/11/25. doi: https://​doi.​org/​10.​1111/​ggi.​14314. PubMed PMID: 34816568.CrossRefPubMed
30.
go back to reference Hwang AC, Liu LK, Lee WJ, Chen LY, Lin MH, Peng LN, et al. Association of androgen with skeletal muscle mass and muscle function among men and women aged 50 years and older in Taiwan: results from the I-Lan longitudinal aging study. Rejuvenation Res. 2013;16:453–9. Epub 2013/08/06. doi: https://doi.org/10.1089/rej.2013.1442. PubMed PMID: 23909377.CrossRefPubMed Hwang AC, Liu LK, Lee WJ, Chen LY, Lin MH, Peng LN, et al. Association of androgen with skeletal muscle mass and muscle function among men and women aged 50 years and older in Taiwan: results from the I-Lan longitudinal aging study. Rejuvenation Res. 2013;16:453–9. Epub 2013/08/06. doi: https://​doi.​org/​10.​1089/​rej.​2013.​1442. PubMed PMID: 23909377.CrossRefPubMed
33.
go back to reference Chen LK, Hwang AC, Lee WJ, Peng LN, Lin MH, Neil DL, et al. Efficacy of multidomain interventions to improve physical frailty, depression and cognition: data from cluster-randomized controlled trials. J Cachexia Sarcopenia Muscle. 2020;11:650–62. Epub 2020/03/07. doi: https://doi.org/10.1002/jcsm.12534. PubMed PMID: 32134208; PubMed Central PMCID: PMCPMC7296266.CrossRefPubMedPubMedCentral Chen LK, Hwang AC, Lee WJ, Peng LN, Lin MH, Neil DL, et al. Efficacy of multidomain interventions to improve physical frailty, depression and cognition: data from cluster-randomized controlled trials. J Cachexia Sarcopenia Muscle. 2020;11:650–62. Epub 2020/03/07. doi: https://​doi.​org/​10.​1002/​jcsm.​12534. PubMed PMID: 32134208; PubMed Central PMCID: PMCPMC7296266.CrossRefPubMedPubMedCentral
Metadata
Title
Long-Term Mortality Risk in Older Adults with Sarcopenia: An 11-Year Prospective Cohort Study Comparing AWGS 2014 and AWGS 2019 Guidelines for Enhanced Clinical Utility and Accurate Risk Prediction
Authors
C.-K. Liang
L.-N. Peng
M.-H. Lin
C.-H. Loh
Wei-Ju Lee
F.-Y. Hsiao
L.-K. Chen
Publication date
27-06-2023
Publisher
Springer Paris
Published in
The journal of nutrition, health & aging / Issue 7/2023
Print ISSN: 1279-7707
Electronic ISSN: 1760-4788
DOI
https://doi.org/10.1007/s12603-023-1940-y

Other articles of this Issue 7/2023

The journal of nutrition, health & aging 7/2023 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.